Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Today

  • Mining curated knowledge graphs and validating with experimental datasets to accelerate your drug target discovery

    Virtual - Americas - EST , United States

    In an era of near-limitless public experimental data but little standardization, meaningful insights are lost to noise. Large collections of quality experimental data are essential for big-picture discoveries that stand up to scrutiny. In this webinar, you will learn how to feed your drug discovery programs by integrating connections mined from QIAGEN Biomedical Knowledge Base […]

  • How biopharmaceutical companies can leverage expert-curated knowledge from Wellcome Sanger Institute and QIAGEN to accelerate cancer drug discovery and development

    Virtual - Americas - EST , United States

    The cancer drug discovery landscape is shifting. While research continues to grow in cost and complexity, the pace of development has never been faster. Biopharmaceutical companies can’t afford to waste time and resources pursuing ineffective or unsafe ideas. In this talk, our experts discuss how biopharmaceutical companies can leverage key genomic, biomedical, and clinical trial […]

  • Public single-cell RNA-seq data investigation using QIAGEN Omicsoft and Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue heterogeneity, identify novel cell types, study pathogenic mechanisms, develop targeted therapy (including immunotherapy) and more. Accordingly, a tremendous amount of scRNA-seq data has been deposited to public domains like GEO.  In this training, you will learn how to  · Locate public single-cell studies of interest using QIAGEN Omicsoft […]

  • Biomarker discovery, target validation, and variant identification using QIAGEN OmicSoft DiseaseLand, Human Gene Mutation Database, and Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    In this webinar, users will learn how to leverage solutions from QIAGEN Digital Insights to discover biomarkers, validate targets, and identify variants. Specifically, users will learn: 1. How to locate public studies of interest using OmicSoft DiseaseLand. 2. Investigate the expression of genes of interest across different treatments, disease states, etc. 3. Identify variants of […]

  • New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)

    Virtual - Americas - EST , United States

    Join us for a 120-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to:  Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more) Compare different experimental conditions […]

  • Featured

    Using COSMIC to predict, identify, and avoid mutational consequences of cancer therapies during early drug development and in patients

    Virtual - Americas - EST , United States

    Whether your lab is researching and developing targeted cancer therapies or you are analyzing and interpreting diagnostic tests at the point-of-care, a critical part of your workflow is understanding the structural and functional impact of cancer-related mutations. The Catalogue Of Somatic Mutations In Cancer (COSMIC) is an expert-curated database encompassing a wide variety of somatic mutation […]

  • Featured

    Using ATCC cell line data for cell line selection, validation and other applications

    Virtual - Americas - EST , United States

    Cancer cell line models have been a cornerstone of cancer research for decades. Profiling cancer cell lines can be a powerful tool to identify gene alterations or cancer-related pathways and aid in discovering putative drug targets. In this webinar, we'll use QIAGEN OmicSoft Lands and QIAGEN Ingenuity Pathway Analysis (IPA) to help you select cell […]

  • Featured

    Expert Roundtable: Advances in Genomic Testing for Rare Disease Diagnostics

    Over the past decade, whole-exome and whole-genome sequencing have transformed the diagnosis of patients with suspected rare genetic diseases. However, despite recent advancements, a large number of patients with rare genetic diseases remains undiagnosed for years because they have limited access to comprehensive genomic testing. In this virtual roundtable of leading rare disease experts, panelists […]

  • How to transition from Agilent Alissa Interpret to a new platform

    Agilent Alissa to QCI Interpret: How can your lab reduce the stress and complexity of transitioning to a new clinical informatics platform?

    Virtual - Americas - EST , United States

    In 2023, Agilent announced the discontinuation of their Alissa Interpret clinical informatics platform by the end of 2024. As a result, many of their current customers need to transition to a new variant interpretation and reporting software within a tight timeframe. However, when evaluating new interpretation solutions, clinical labs must consider a variety of factors, […]

  • Single-Cell RNA-Seq, Cell Hashing, and Spatial Transcriptomics

    Virtual - Americas - EST , United States

    A slide illustrating some of the many result types/graphics you will be able to generate after this training. https://qiagen.showpad.com/share/jYTCDPNfz1SdIMPQPSPYS  Description: In this training, you will learn how to analyze and interpret your own single-cell RNA-seq data using QIAGEN CLC Genomics Workbench, starting with either FASTQ or matrix files.  Using CLC Genomics Workbench, you will learn how to perform […]

  • Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis

    Virtual - Americas - EST , United States

    This 90-minute training session will show you how QIAGEN Ingenuity Pathway Analysis (IPA) visualizes molecular intricacies and variations at the transcriptome, proteome and metabolome levels. Through a series of brief technical vignettes, you will learn how to: • Generate associations among molecular signatures obtained by integrating multi-omics data  • Extract mechanisms from multi-omics data for precision medicine  • […]

  • How to scale-up comprehensive genomic profiling and deliver confident variant interpretations with QCI Interpret for Oncology

    Virtual - Americas - EST , United States

    In this webinar, attendees will learn how QCI Interpret for Oncology enables you to: Navigate from VCF to final report with speed, precision, and confidence; Easily issue report addendums without the need for re-running a VCF; Streamline structural variant filtering based on user-set thresholds and hence reduce the time and effort needed to eliminate noise […]